Answers are grounded in this paper and cite their sources.
Background Residents of long-term care facilities (LTCFs) often experience medication-related problems. With the introduction of pharmacists working on-site in Australian LTCFs, there is a need to support interprofessional collaborative practice to improve quality use of medicines. Medication Safety Needs Rounds (needs rounds hereafter) build on the evidence-based principles of palliative care needs rounds to support interprofessional collaboration and communication in LTCFs. Needs rounds involve proactively identifying residents at potential risk of medication-related harm, discussing these residents at monthly interprofessional triage meetings, and implementing follow-up actions to support quality use of medicines. This study aims to examine the feasibility and scalability of needs rounds in LTCFs. Methods We will conduct a mixed-methods feasibility study following the implementation of needs rounds in LTCFs to answer the overarching question: ‘Can it work?’. An iterative co-design process has already engaged residents, supporters, health professionals and LTCF staff to refine the model and develop implementation materials. Needs rounds will be implemented in six LTCFs over six months, with informed consent sought from LTCFs and individuals involved in evaluation activities. Our process and outcome evaluation will describe feasibility, including acceptability, practicality, adaptation, integration and implementation processes, outcome measures, impact and demand, and costs. The evaluation will be informed by documentation and tracking of needs rounds activities and costs, quantitative data including quality indicators, a pre- and post-implementation online survey, observations of needs rounds meetings, and interviews/focus groups. Using data collected throughout the evaluation, a scalability assessment and workshop will determine the suitability of needs rounds for further testing and wider implementation or scale-up. Discussion This protocol outlines a robust mixed-methods evaluation of the feasibility and scalability of needs rounds in LTCFs. In addition to supporting outcomes for the individual residents reviewed during meetings, we anticipate immediate impacts on quality use of medicines at participating LTCFs. We will utilise targeted dissemination strategies to ensure key stakeholders receive essential information about the scalability and potential impacts of Medication Safety Needs Rounds to inform subsequent implementation steps. Trial registration This study has been prospectively registered (10/07/2026) with the Australian New Zealand Clinical Trials Registry (registration number ACTRN12626000836336, Universal Trial Number U1111-1341-5394).
No takes yet. Share an insight, caveat, or question.
Hughes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: